Results 261 to 270 of about 36,666,975 (299)
Some of the next articles are maybe not open access.

Autoantibodies in Type 1 diabetes

Diabetes Research and Clinical Practice, 2010
Type 1 diabetes is an autoimmune disease manifested by an autoimmune attack on the pancreatic beta-islet cells. It is also known that Type 1 diabetes is associated with other autoimmune diseases. The aim of the present study was to seek autoantibodies in the serum of people with Type 1 diabetes.
Panagiotis, Heras   +7 more
openaire   +2 more sources

Microchimerism in type 1 diabetes

Current Diabetes Reports, 2009
The observation that maternal cells can transfer from mother to child during pregnancy and differentiate into many different tissues including islet beta cells is exciting and intriguing, and to date has generated more questions than answers: Could these genetically distinct maternal cells play a role in the initiation of autoimmune diabetes in the ...
vanZyl, B, Gillespie, KM
openaire   +2 more sources

The geoepidemiology of type 1 diabetes

Autoimmunity Reviews, 2010
Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by absolute insulin deficiency resulting from the progressive immune-mediated destruction of pancreatic islet beta cells. It is thought to be triggered by as yet unidentified environmental factors in genetically susceptible individuals, the major genetic contribution coming from loci ...
Andrea T, Borchers   +2 more
openaire   +2 more sources

Management of Type 1 Diabetes

Nursing Clinics of North America, 2017
Comprehensive type 1 diabetes management requires understanding of the pathophysiology of disease and the ability to contrast this process with type 2 diabetes. Nurses are often the first contact with patients and must be aware of the advancements in detection, therapies, and signs of complications in these patients.
openaire   +2 more sources

Treg in type 1 diabetes

Cell Biochemistry and Biophysics, 2007
At the time of this writing, a major void exists; the lack of a method to prevent and/or reverse type 1 diabetes in humans. We believe this void to a large extent is the result of our lack in understanding the mechanisms of autoimmunity that underlie beta cell destruction, a failure to understand the immunologic factors that contribute to type 1 ...
Todd, Brusko, Mark, Atkinson
openaire   +2 more sources

Management of Type 1 Diabetes

Primary Care: Clinics in Office Practice, 2007
Although less prevalent than type 2 diabetes, autoimmune type 1 diabetes presents numerous challenges, including many that must be addressed daily. Patients must have appropriate tools to confront and manage their physiologic insulin deficiency syndrome.
openaire   +2 more sources

Economics of Type 1 Diabetes

Endocrinology and Metabolism Clinics of North America, 2010
This article reviews economic methodologies developed for estimating cost of illness, examines the current literature on diabetes costs, and presents the latest estimates of the economic impact of type 1 diabetes in terms of direct medical costs (ie, treatment costs) and indirect costs (eg, lost wages).
Betty T, Tao, David G, Taylor
openaire   +2 more sources

Genetics of Type 1 Diabetes

2012
Type 1 diabetes has a strong genetic component but additional environmental factors have also an essential role. This is demonstrated by the multifold rise in incidence of the disease during the last decades in most industrialized countries. The most important genes are located within the HLA region, where class II genes largely define the disease risk.
Hermann, Robert, Ilonen, Jorma
openaire   +2 more sources

Management of type 1 diabetes

The Foundation Years, 2002
Abstract Failure of the thyroid gland requires thyroid hormone replacement therapy, which is relatively easily adjusted to replicate the normal physiological state by monitoring plasma levels of thyroxine and/or thyroid-stimulating hormone. In contrast, failure of pancreatic b-cells requires insulin therapy, and optimal replacement requires monitoring,
openaire   +1 more source

PREVENTION OF TYPE 1 DIABETES

Medical Clinics of North America, 1998
This article discusses type 1 diabetes mellitus, which results from insulin deficiency caused by autoimmune destruction of the insulin-producing beta-cells in the pancreatic islets of Langerhans. The autoimmune response against islet beta-cells is believed to result from a disorder of immunoregulation. According to this concept, T lymphocytes (T cells)
A, Rabinovitch, J S, Skyler
openaire   +2 more sources

Home - About - Disclaimer - Privacy